KAMERON MURRAY: Open Payments
NPI 1174248389 · HOLDREGE, NE. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$845 in 33 payments from 10 companies in 2025. Trend: 2023 $435 · 2024 $414 · 2025 $845
Food & beverage: $845
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 10 | $371 |
| ABBVIE INC. | 10 | $178 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 3 | $85 |
| Insulet Corporation | 1 | $57 |
| Novo Nordisk Inc | 3 | $49 |
| Amgen Inc. | 2 | $41 |
| VERTEX PHARMACEUTICALS INCORPORATED | 1 | $21 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $15 |
| Lilly USA, LLC | 1 | $14 |
| PFIZER INC. | 1 | $14 |
Products named: FARXIGA, QULIPTA, CAPLYTA, AIRSUPRA, BREZTRI, Omnipod, VRAYLAR, EVENITY.
Industry payments across NE — which companies pay providers there.
